scispace - formally typeset
K

Kumar Dharmarajan

Researcher at Yale University

Publications -  106
Citations -  7667

Kumar Dharmarajan is an academic researcher from Yale University. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 31, co-authored 103 publications receiving 6560 citations. Previous affiliations of Kumar Dharmarajan include Peking Union Medical College & Harvard University.

Papers
More filters
Journal ArticleDOI

Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia.

TL;DR: There was no evidence for increase in in-hospital or postdischarge mortality associated with the HRRP announcement or implementation—a period with substantial reductions in readmissions.
Journal ArticleDOI

Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions

TL;DR: High performing hospitals have proportionately fewer 30 day readmissions without differences in readmission diagnoses and timing, suggesting the possible benefit of strategies that lower risk of readmission globally rather than for specific diagnoses or time periods after hospital stay.
Journal ArticleDOI

Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study

TL;DR: Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia in adults aged 18 to 64 years with readmissions in those aged 65 and older are compared.
Journal ArticleDOI

Hospital-Readmission Risk - Isolating Hospital Effects from Patient Effects.

TL;DR: The findings suggest that hospital quality contributes in part to readmission rates independent of factors involving patients.
Journal ArticleDOI

Variation Exists in Rates of Admission to Intensive Care Units for Heart Failure Patients Across Hospitals in the United States

TL;DR: ICU admission rates for HF varied markedly across hospitals and lacked association with in-hospital risk-standardized mortality, suggesting judicious ICU use could reduce resource consumption without diminishing patient outcomes.